What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesA MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
A close look at the stock most likely to join the $1 trillion club soon. Learn the catalysts, how to buy, and risk co...
A single insider move often sparks headlines, but context matters. This article digs into what this credo insider's s...
Alphabet’s Q1 2026 results show stronger-than-expected search growth and record cloud momentum, challenging the AI be...
Ethereum holds above $2,000 as it eyes $2,400, while XRP rebounds beyond $1.40. ADA sinks below 28 cents, BNB climbs,...
Kraken has introduced regulated crypto spot margin trading in the United States, leveraging Bitnomial licenses acquir...
A new defense startup is challenging traditional missiles with a car-like manufacturing model, backed by a $5 million...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
Income investors are weighing two popular S&P 500 covered-call ETFs. This piece breaks down how SPYI and JEPI generat...
Two retail giants dominate the home improvement space as 2026 unfolds. This guide digs into Lowe's and The Home Depot...
Antero Resources is attracting takeover chatter as major energy players weigh bids. With strong cash flow and LNG exp...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.